For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241210:nRSJ4067Pa&default-theme=true
RNS Number : 4067P Greencoat UK Wind PLC 10 December 2024
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR
INTO, THE UNITED STATES (INCLUDING ITS TERRITORIES AND POSSESSIONS, ANY STATE
OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA), AUSTRALIA, CANADA, NEW
ZEALAND, THE REPUBLIC OF SOUTH AFRICA OR JAPAN.
GREENCOAT UK WIND PLC
(the "Company")
Revision to Investment Management Agreement
The Board of Greencoat UK Wind today announces that it has agreed with its
investment manager, Schroders Greencoat LLP, to revise the terms of the
Investment Management Agreement ("IMA") with effect from 1 January 2025. Under
the terms of the revised IMA, the current fee thresholds and rates applied
remain unchanged but the basis of the investment management fee calculation
will be the lower of market capitalisation and net asset value. The revised
IMA includes other immaterial amendments.
Lucinda Riches, Chairman of Greencoat UK Wind, said: "Following constructive
discussions with the Investment Manager, we are pleased to be able to announce
this revised fee structure which will foster even stronger alignment with
shareholders."
For further information, please contact:
Greencoat UK Wind PLC
020
7832 9425
Stephen Lilley
Matt Ridley
Ocorian Administration (UK) Limited Company
Secretary 028 9693 0219
Josh
Finlay
Headland 020
3805 4822
Stephen Malthouse
Rob Walker
Charlie Twigg
ukwind@headlandconsultancy.com (mailto:ukwind@headlandconsultancy.com)
Disclaimer
This announcement is not for publication or distribution, directly or
indirectly, in or into the United States (including its territories and
possessions, any state of the United States and the District of Columbia),
Australia, Canada, New Zealand, South Africa or Japan. The distribution of
this announcement may be restricted by law in certain jurisdictions and
persons into whose possession any document or other information referred to
herein comes should inform themselves about and observe any such restriction.
Any failure to comply with these restrictions may constitute a violation of
the securities laws of any such jurisdiction.
This announcement does not contain or constitute an offer for sale of, or the
solicitation of an offer or an invitation to buy or subscribe for, Ordinary
Shares to any person in the United States, Australia, Canada, New Zealand,
South Africa or Japan or in any jurisdiction to whom or in which such offer or
solicitation is unlawful.
The Company will not be registered under the US Investment Company Act of
1940, as amended. In addition, the Ordinary Shares referred to herein have not
been and will not be registered under the US Securities Act of 1933 (the
"Securities Act") or under the securities laws of any state of the United
States and may not be offered or sold in the United States or to or for the
account or benefit of US persons absent registration or pursuant to an
exemption from, or in a transaction not subject to, the registration
requirements of the Securities Act and in compliance with any applicable State
securities laws. The offer and sale of Ordinary Shares referred to herein has
not been and will not be registered under the Securities Act or under the
applicable securities laws of any state, province or territory of Australia,
Canada, New Zealand, South Africa or Japan. Subject to certain exceptions, the
Ordinary Shares referred to herein may not be offered or sold in Australia,
Canada, New Zealand, South Africa or Japan or to, or for the account or
benefit of, any national, resident or citizen of Australia, Canada, New
Zealand, South Africa or Japan. There will be no public offer of the Ordinary
Shares in the United States, Australia, Canada, New Zealand, South Africa or
Japan.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END UPDTLBPTMTMMBFI